Otitis externas crónicas recurrentes en caninos: manejo farmacológico y nuevas alternativas terapéuticas para un tratamiento exitoso
DOI:
https://doi.org/10.24215/15142590e077Palabras clave:
otitis externa, Pseudomonas aeruginosa, caninos, nuevas terapiasResumen
La otitis externa “crónica” canina es aquella que perdura por más de un mes, y es “recurrente” cuando ocurre más de un episodio en el transcurso de un año. Es una afección multifactorial con una fisiopatología compleja y de difícil resolución. Para el tratamiento médico es fundamental la reducción del proceso inflamatorio, el manejo del dolor y la selección racional del antimicrobiano más adecuado para minimizar los fenómenos de resistencia. Es imprescindible conocer las diferentes opciones terapéuticas que permitan reducir el daño provocado por las bacterias o levaduras, que perpetúan las otitis crónicas en los caninos, y luego abocarse al tratamiento de la enfermedad primaria. Actualmente existe un creciente progreso en la investigación de nuevas alternativas terapéuticas al uso de los antimicrobianos. Entre ellas podemos citar el uso de aceites esenciales, productos naturales como la miel y sus derivados, investigación de coadyuvantes como N-acetilcisteína o EDTA, vacunas, nano-formulaciones y el estudio de nuevos péptidos. En esta revisión se analizan las diferentes alternativas terapéuticas para el manejo exitoso de las otitis crónicas y recurrentes. Las mismas pueden mejorar la calidad de vida y el bienestar del paciente, maximizar la eficacia del tratamiento y minimizar la aparición de fenómenos de resistencia antimicrobiana que afectan la salud animal, al hombre y al entorno.
Descargas
Métricas
Citas
Aoki W, Ueda M. 2013. Characterization of antimicrobial peptides toward the development of novel antibiotics. Pharmaceuticals (Basel). 6(8):1055-81. https://doi.org/10.3390/ph6081055
Aprea A, Giordano A, Baschar H, Broglia G, Bonzo E. 2006. Otoendoscopía en caninos: primera etapa. Analecta Veterinaria. 26(2):25-8.
Bajwa J. 2017. Canine Malassezia dermatitis. The Canadian Veterinary Journal - La Revue Veterinaire Canadienne, 58(10), 1119–21.
Bajwa J. 2019. Canine otitis externa. Treatment and complications. The Canadian Veterinary Journal - La Revue Veterinaire Canadienne, 60(1):97-9.
Bamburowicz-Klimkowska M, Popławska M, Grudziński IP. 2019. Nanocomposites as biomolecules delivery agents in nanomedicine. Journal of Nanobiotechnology. 17(1):48. https://doi.org/10.1186/s12951-019-0479-x
Barnard N, Foster A. 2017. Pseudomonas otitis in dogs: a a general practitioner's guide to treatment. In Practice. 39(9):386-98. https://doi.org/10.1136/inp.j892
Batoni G, Maisetta G, Esin S. 2016. Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria. Biochimica et Biophysica Acta. 1858(5):1044-60. https://doi.org/10.1016/j.bbamem.2015.10.013
Becskei C, Cuppens O, Mahabir S. 2018. Efficacy and safety of sarolaner in the treatment of canine ear mite infestation caused by Otodectes cynotis: a non-inferiority study. Veterinary Dermatology. 29:100-e39. https://doi.org/10.1111/vde.12521
Bellah J. Oído. En: Bojrab MJ, Monnet E .2011. Mecanismos de enfermedad en cirugía de pequeños animales. Ciudad Autónoma de Buenos Aires. 3ª ed., Editorial Inter-Médica. pp 332-46.
Ben-Khalifa R, Gaspar FB, Pereira C, Chekir-Ghedira L, Rodríguez-Rojo S. 2021. Essential oil and hydrophilic antibiotic co-encapsulation in multiple lipid nanoparticles: proof of concept and in vitro activity against Pseudomonas aeruginosa. Antibiotics (Basel, Switzerland). 10(11):1300. https://doi.org/10.3390/antibiotics10111300
Bond R, Morris DO, Guillot J, Bensignor EJ, Robson D, Mason KV, Kano R, Hill PB. 2020. Biology, diagnosis and treatment of Malassezia dermatitis in dogs and cats. Clinical Consensus Guidelines of the World Association for Veterinary Dermatology. Veterinary Dermatology. 31(1):28-74. https://doi.org/10.1111/vde.12809
Broglia G, Giordano A, Baschar H, Galarza E, Diez M, Bonzo E, Aprea A. 2005. Otoendoscopía en caninos - primera etapa. Proceedings 5° Congreso Nacional de la Asociación de Veterinarios Especializados en Animales de Compañía de Argentina (AVEACA). Buenos Aires, Argentina.
Broglia G, Giordano A, Acosta W, Villanueva M, Diez M, Bonzo E, Aprea A. 2006. Otoendoscopía en caninos - segunda etapa. Presentación de casos. Proceedings 6° Congreso Nacional de la Asociación de Veterinarios Especializados en Animales de Compañía de Argentina (AVEACA). Buenos Aires, Argentina.
Broglia G, Borrelli S. Enfermedades del oído. En: Brusa M. 2014. Compendio de enfermedades de los caninos y felinos domésticos. La Plata, Editorial de la Universidad Nacional de La Plata (Edulp), pp 396-413.
Broglia G, Marchetti L, Buchamer A, Mestorino, N. 2020. Pseudomonas aeruginosa en la otitis externa canina: situación actual. Analecta Veterinaria. 40(1):13-24. https://doi.org/10.24215/15142590e048
Buckley LM, Mc Ewan NA, Nuttall T. 2013. Tris-EDTA significantly enhances antibiotic efficacy against multidrug-resistant Pseudomonas aeruginosa in vitro. Veterinary Dermatology. 24(5):519-e122. https://doi.org/10.1111/vde.12071
Budgen D. 2013. Identification and antibiotic susceptibility of bacterial isolates from dogs with otitis externa in Australia. Australian Veterinary Journal. 91(1-2):43-46. https://doi.org/10.1111/avj.12007
Buldain D, Buchamer A, Marchetti L, Aliverti F, Borja C, Mestorino N. 2017. Efecto antimicrobiano de la combinación de cloxacilina con aceite esencial de Melaleuca armillaris frente a Staphylococcus aureus. Analecta Veterinaria. 37(2):014. https://doi.org/10.24215/15142590e014
Buldain D., Buchamer AV., Marchetti ML., Aliverti F., Bandoni A., Mestorino N. 2018. Combination of cloxacillin and essential oil of Melaleuca armillaris as an alternative against Staphylococcus aureus. Frontiers in Veterinary Science. 5:177. https://doi.org/10.3389/fvets.2018.00177
Buldain D, Gortari Castillo L, Buchamer AV, Bandoni A, Marchetti L, Mestorino N. 2022. In vitro synergistic interaction between Melaleuca armillaris essential oil and erythromycin against Staphylococcus aureus isolated from dairy cows. Frontiers in Veterinary Science. 9:1005616. https://doi.org/10.3389/fvets.2022.1005616
Cárcamo G, Lumjiaktase P, Kummerli R, Eberl L. 2014. Quorum sensing triggers the stochastic escape of individual cells from Pseudomonas putida biofilms. Nature Communications. 6(1): 5945-59. https://doi.org/10.1038/ncomms6945
Chang CY, Krishnan T, Wang H, Chen Y, Yin WF, Chong YM, Tan LY, Chong TM, Chan KG. 2014. Non-antibiotic quorum sensing inhibitors acting against N-acyl homoserine lactone synthase as druggable target. Scientific reports. 4:7245-52. https://doi.org/10.1038/srep07245
Chatterjee M, Anju CP, Biswas L, Anil Kumar V, Gopi Mohan C, Biswas R. 2016. Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options. International Journal of Medical Microbiology. 306(1):48-58. https://doi.org/10.1016/j.ijmm.2015.11.004
Chiavassa E, Tizzani P, Peano A. 2014. In vitro antifungal susceptibility of Malassezia pachydermatis strains isolated from dogs with chronic and acute otitis externa. Mycopathologia. 178(3-4):315-9. https://doi.org/10.1007/s11046-014-9782-0
Cremers N, Belas A, Santos Costa S, Couto I, de Rooster H, Pomba C. 2020. In vitro antimicrobial efficacy of two medical grade honey formulations against common high-risk meticillin-resistant staphylococci and Pseudomonas spp. pathogens. Veterinary Dermatology. 31(2):90-96. https://doi.org/10.1111/vde.12811
Curtis CF. 2004. Current trends in the treatment of Sarcoptes, Cheyletiella and Otodectes mite infestations in dogs and cats. Veterinary Dermatology. 15(2),108-14. https://doi.org/10.1111/j.1365-3164.2004.00362.x
de Celis M, Serrano-Aguirre L, Belda I, Liébana-García R, Arroyo M, Marquina D, de la Mata I, Santos A. 2021. Acylase enzymes disrupting quorum sensing alter the transcriptome and phenotype of Pseudomonas aeruginosa, and the composition of bacterial biofilms from wastewater treatment plants. Science of the total environment. 799, 149401. https://doi.org/10.1016/j.scitotenv.2021.149401
de Lacerda Coriolano D, de Souza JB, Bueno EV, Medeiros SMFRDS, Cavalcanti IDL, Cavalcanti IMF. 2021. Antibacterial and antibiofilm potential of silver nanoparticles against antibiotic-sensitive and multidrug-resistant Pseudomonas aeruginosa strains. Brazilian Journal of Microbiology (publication of the Brazilian Society for Microbiology). 52(1):267-78. https://doi.org/10.1007/s42770-020-00406-x
Dhar S, Seth J, Parikh D. 2014. Systemic side-effects of topical corticosteroids. Indian Journal of Dermatology. 59(5):460-4. https://doi.org/10.4103/0019-5154.139874
Domínguez-Oliva A, Casas-Alvarado A, Miranda-Cortés AE, Hernández-Avalos I. 2021. Clinical pharmacology of tramadol and tapentadol, and their therapeutic efficacy in different models of acute and chronic pain in dogs and cats. Journal of Advanced Veterinary and Animal Research. 8(3):404-22. https://doi.org/10.5455/javar.2021.h529
Doyle RS, Skelly C, Bellenger CR. 2004. Surgical management of 43 cases of chronic otitis externa. Irish Veterinary Journal. 57(1): 22-30. https://doi.org/10.1186/2046-0481-57-1-22
Düzgüneş N, Sessevmez M, Yildirim M. 2021. Bacteriophage therapy of bacterial infections: the rediscovered frontier. Pharmaceuticals (Basel, Switzerland). 14(1) 34. https://doi.org/10.3390/ph14010034
El-Feky MA, El-Rehewy MS, Hassan MA, Abolella HA, Abd El-Baky RM, Gad GF. 2009. Effect of ciprofloxacin and N-acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces. Polish Journal of Microbiology. 58(3):261-7.
Escribano C, Ordeix L, Pol G, Puigdemont A, Brazis P. 2009. Sensibilidad de Pseudomonas spp. frente a las quinolonas en infecciones óticas y cutáneas en el perro y en el gato. Clínica veterinaria de pequeños animales: revista oficial de AVEPA, Asociación Veterinaria Española de Especialistas en Pequeños Animales. 29(4):203-7.
Ference J, Last A. 2009. Choosing topical corticosteroids. American Family Physician. 79(2):135-40.
Food and Agriculture Organization of the United Nations/World Organization for Animal Health/World Health Organization (FAO/WHO/OIE). 2007. Joint FAO/WHO/OIE Expert Meeting on Critically Important Antimicrobials. Report of the FAO/WHO/OIE Expert Meeting FAO Headquarters, Rome 26-30 November 2007. http://www.fao.org/3/a-i0204e.pdf [Consultado 19 de agosto de 2023]
French VM, Cooper RA, Molan PC. 2005. The antibacterial activity of honey against coagulase-negative staphylococci. The Journal Antimicrobial Chemotherapy. 56(1):228-31. https://doi.org/10.1093/jac/dki193
Gaviria A, Cruz JM. 2018. Otitis media en el perro: diagnóstico, tratamiento quirúrgico y posibles complicaciones. Revisión. Revista de Medicina Veterinaria y de Zootecnia. 65(2): 179-89. https://doi.org/10.15446/rfmvz.v65n2.75641
Ghubash R. 2006. Parasitic miticidal therapy. Clinical Techniques in Small Animal Practice. 21(3):135-44. https://doi.org/10.1053/j.ctsap.2006.05.006
Gómez-García M, Madrigal I, Puente H, Mencía-Ares Ó, Argüello H, Carvajal A, Fregeneda-Grandes JM. 2022. In vitro activity of essential oils against microbial isolates from otitis externa cases in dogs. Natural Product Research. 36(17):4552-6. https://doi.org/10.1080/14786419.2021.1993217
Gotthelf LN. 2004. Diagnosis and treatment of otitis media in dogs and cats. The Veterinary Clinic of North America. Small Animal Practice. 34(2):469-87. https://doi.org/10.1016/j.cvsm.2003.10.007
Hariharan H, Coles M, Poole D, Lund L, Page R. 2006. Update on antimicrobial susceptibilities of bacterial isolates from canine and feline otitis externa. Canadian Veterinary Journal - La Revue Veterinaire Canadienne. 47(3):253-5.
Henatsch D, Nabuurs CH, van de Goor RM, Wolffs PF, Stokroos RJ. 2017. Treatment of recurrent eczematous external otitis with honey eardrops: A proof-of-concept study. Otolaryngology-Head and Neck Surgery. 157(4):696-9. https://doi.org/10.1177/0194599817718782
Hirsch EB, Tam VH. 2010. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Expert Review of Pharmacoeconomics & Outcomes Research. 10(4):441-51. https://doi.org/10.1586/erp.10.49
Hurley MN, Cámara M, Smyth AR. 2012. Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. The European Respiratory Journal. 40(4):1014-23. https://doi.org/10.1183/09031936.00042012
Imperi F, Massai F, Ramachandran Pillai C, Longo F, Zennaro E, Rampioni G, Visca P, Leoni L. 2013. New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing. Antimicrobials Agents and Chemotheraphy.
(2):996-1005. https://doi.org/10.1128/AAC.01952-12
Jacobson L. 2002. Diagnosis and medical treatment of otitis externa in the dog and cat. Journal South African Veterinary Association. 73(4):162-70. https://doi.org/10.4102/jsava.v73i4.581
Johansen HK, Gøtzsche PC. 2015. Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis. The Cochrane database of systematic reviews. 2015(8):CD001399. https://doi.org/10.1002/14651858.CD001399.pub4
Kalia VC. 2013. Quorum sensing inhibitors: An overview. Biotechnology Advances. 31(2):224-45. https://doi.org/10.1016/j.biotechadv.2012.10.004
Kalia VC, Patel SKS, Kang YC, Lee JK. 2019. Quorum sensing inhibitors as antipathogens: biotechnological applications. Biotechnology Advances. 37(1):68-90. https://doi.org/10.1016/j.biotechadv.2018.11.006
Karlapudi SK. 2017. Diagnosis and management of Malassezia otitis in dogs. The Pharma Innovation Journal. 6(9):36-8.
Krahwinkel D. Canal auditivo externo. En: Slatter D. 2006. Tratado de Cirugía en Pequeños Animales 3ª ed. Ciudad Autónoma de Buenos Aires, Editorial Inter-Médica. 122:2000-11.
Layne A, de Miguel Garcia C. 2019. Clinical techniques in Veterinary Dermatology: Regional anesthesia of the canine ear. Veterinary Dermatology. 30(6):470-e138. https://doi.org/10.1111/vde.12792
Léonard C, Taminiau B, Ngo J, Fantini O, Daube G, Fontaine J. 2021. Preventive use of a topical anti-inflammatory glucocorticoid in atopic dogs without clinical sign of otitis does not affect ear canal microbiota and mycobiota. Veterinary Dermatology. 32(4):355-e98. https://doi.org/10.1111/vde.12977
Ly-Chatain MH. 2014. The factors affecting effectiveness of treatment in phages therapy. Frontiers in Microbiology. 5(51): 1-7. https://doi.org/10.3389/fmicb.2014.00051
Mandal MD, Mandal S. 2011. Honey: its medicinal property and antibacterial activity. Asian Pacific Journal of Tropical Biomedicine. 1(2):154-60. https://doi.org/10.1016/S2221-1691(11)60016-6
Maruhashi E, Braz BS, Nunes T, Pomba C, Belas A, Duarte-Correia JH, Lourenço AM. 2016. Efficacy of medical grade honey in the management of canine otitis externa - a pilot study. Veterinary Dermatology. 27(2):93-8e27. https://doi.org/10.1111/vde.12291
May ER, Conklin KA, Bemis DA. 2016. Antibacterial effect of N-acetylcysteine on common canine otitis externa isolates. Veterinary Dermatology. 27(3):188-e47. https://doi.org/10.1111/vde.12313
May ER, Ratliff BE, Bemis DA. 2019. Antibacterial effect of N-acetylcysteine in combination with antimicrobials on common canine otitis externa bacterial isolates. Veterinary Dermatology. 30(6):531-e161. https://doi.org/10.1111/vde.12795
Mestorino N. 2006. Antibioticoterapia racional de enfermedades respiratorias en pequeños animales. Proceedings 6º Congreso Nacional de la Asociación de Veterinarios Especializados en Animales de Compañía de Argentina (AVEACA). Buenos Aires, Argentina, pp 76-87.
Miller W, Griffin C, Campbell K. Capítulo 19: Enfermedades de los párpados, uñas, sacos anales y conductos auditivos. En: Muller & Kirk. 2014. Dermatología en pequeños animales, séptima edición. Buenos Aires, Editorial Inter-Médica, pp 2:830-1.
Moraru R, Chermette R, Guillot J. 2019. Superficial mycoses in dogs and cats. En: Singh, K., Srivastava, N. (eds). Recent trends in human and animal mycology. Springer, Singapore, pp 27-45. https://doi.org/10.1007/978-981-13-9435-5_2
Mueller RS, Bergvall K, Bensignor E, Bond R. 2012. A review of topical therapy for skin infections with bacteria and yeast. Veterinary Dermatology. 23(4):330-e62. https://doi.org/10.1111/j.1365-3164.2012.01057.x
Muñoz-Cázares N, Castillo-Juárez I, García-Contreras R, Castro-Torres VA, Díaz-Guerrero M, Rodríguez-Zavala JS, Quezada H, González-Pedrajo B, Martínez-Vázquez MA. 2022. A brominated furanone inhibits Pseudomonas aeruginosa quorum sensing and type III secretion, attenuating its virulence in a murine cutaneous abscess model. Biomedicines. 10(8):1847. https://doi.org/10.3390/biomedicines10081847
Neves RCSM, Makino H, Cruz TPPS, Silveira MM, Sousa VRF, Dutra V, Lima MEKM, Belli CB. 2018. In vitro and in vivo efficacy of tea tree essential oil for bacterial and yeast ear infections in dogs. Pesquisa Veterinaria Brasileira. 38(8):1597-607. https://doi.org/10.1590/1678-5150-PVB-5055
Ngo J, Taminiau B, Aboulaye Fall P, Daube G, Fontaine J. 2018. Ear canal microbiota - a comparison between healthy dogs and atopic dogs without clinical signs of otitis externa. Veterinary Dermatology. 29(5):425-e140. https://doi.org/10.1111/vde.12674
Nunes Rodrigues TC, Vandenabeele SI. 2021. Pilot study of dogs with suppurative and non-suppurative Malassezia otitis: A case series. BMC Veterinary Research. 17(353). https://doi.org/10.1186/s12917-021-03066-7
Núñez AH, Hidalgo FG, Morales PC, Silva VE, Thomson PE, Castro RA. 2022. Antifungal susceptibility of Malassezia pachydermatis isolated from the external auditive conduct from dogs, in central Chile. Open Veterinary Journal. 12(1):99-104. https://doi.org/10.5455/OVJ.2022.v12.i1.12
Nuttall T. 2019. Managing chronic and recurrent otitis externa in dogs. Veterinary Practice Today. [En línea]. Disponible en: http://vetpracticetoday.com/vpt-en/catalogs/vpt6-6_otis/pdf/complete.pdf. [Consultado: 4/4/2023]
Nuttall T, Bensignor E. 2014. A pilot study to develop an objective clinical score for canine otitis externa. Veterinary Dermatology. 25(6):530-e92. https://doi.org/10.1111/vde.12163
Nuttall T. 2016. Successful management of otitis externa. In Practice. 38(52):17-21. https://doi.org/10.1136/inp.i1951
Oliveira LC, Leite CA, Brilhante RS, Carvalho CB. 2008. Comparative study of the microbial profile from bilateral canine otitis externa. Canadian Veterinary Journal - La Revue Veterinaire Canadienne. 49(8):785-8.
Panarese R, Iatta R, Lia RP, Lebon W, Beugnet F, Otranto D. 2021. Efficacy of afoxolaner for the treatment of ear mite infestation under field conditions. Veterinary Parasitology. 300:109607. https://doi.org/10.1016/j.vetpar.2021.109607
Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. 2019. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnology Advances. 37(1):177-92. https://doi.org/10.1016/j.biotechadv.2018.11.013
Papich MG. 2021. Gabapentin. En: Papich Handbook of Veterinary Drugs (Fifth Edition) W.B. Saunders. pp.398-400. https://doi.org/10.1016/B978-0-323-70957-6.00233-8
Paterson S, Matyskiewicz W. 2018. A study to evaluate the primary causes associated with Pseudomonas otitis in 60 dogs. The Journal of Small Animal Practice. 59(4);238-42. https://doi.org/10.1111/jsap.12813
Paterson S. 2009. Manual de enfermedades de la piel en perros y gatos. 2ª Edición. Ciudad Autónoma de Buenos Aires, Editorial Inter-Médica, pp. 113-5.
Paterson S. 2016. Topical ear treatment- options, indications and limitations of current therapy. The Journal of Small Animal Practice. 57(12):668-78. https://doi.org/10.1111/jsap.12583
Paterson S. 2017. The role of biofilms in otitis. Veterinary Practice. [En línea]. Disponible en: https://www.dermatoclinica.com.br/wp-content/uploads/2021/01/Biofilms-otitis.pdf [Consultado: 15/6/23]
Peano A, Johnson E, Chiavassa E, Tizzani P, Guillot J, Pasquetti M. 2020. Antifungal Resistance Regarding Malassezia pachydermatis: Where Are We Now?. Journal of Fungi (Basel, Switzerland). 6(2):93. https://doi.org/10.3390/jof6020093
Peek NFAW, Nell MJ, Brand R, Jansen-Werkhoven T, van Hoogdalem EJ, Verrijk R, Vonk MJ, Wafelman AR, Valentijn ARPM, Frijns JHM, Hiemstra PS, Drijfhout JW, Nibering PH, Grote JJ. 2020. Ototopical drops containing a novel antibacterial synthetic peptide: Safety and efficacy in adults with chronic suppurative otitis media. PloS One. 15(4):e0231573. https://doi.org/10.1371/journal.pone.0231573
Priebe GP, Goldberg JB. 2014. Vaccines for Pseudomonas aeruginosa: a long and winding road. Expert Review of Vaccines. 13:4:507-19 https://doi.org/10.1586/14760584.2014.890053
Pulido A, Castañeda RS, Linares ML, Mercado MG. 2010. Diagnóstico clínico-microbiológico de otitis externa en caninos de Bogotá, – Colombia. Revista MVZ Córdoba. 15(3):2215-22. https://doi.org/10.21897/rmvz.308
Raval YS, Mohamed A, Song J, Greenwood-Quaintance KE, Beyenal H, Patel R. 2020. Hydrogen peroxide-generating electrochemical scaffold activity against trispecies biofilms. Antimicrobial agents and chemotherapy. 64(4):e02332-19. https://doi.org/10.1128/AAC.02332-19
Ramalingam B, Parandhaman T, Das SK. 2016. Antibacterial effects of biosynthesized silver nanoparticles on surface ultrastructure and nano-mechanical properties of gram-negative bacteria viz. Escherichia coli and Pseudomonas aeruginosa. ACS Applied materials & interfaces. 8(7):4963-76. https://doi.org/10.1021/acsami.6b00161
Ranneh Y, Akim AM, Hamid HA, Khazaai H, Fadel A, Zakaria ZA, Albujja M, Bakar MFA. 2021. Honey and its nutritional and anti-inflammatory value. BMC Complementary Medicine and Therapies. 21(1):30. https://doi.org/10.1186/s12906-020-03170-5
Reeder CJ, Griffin CE, Polissar NL, Neradilek B, Armstrong RD. 2008. Comparative adrenocortical suppression in dogs with otitis externa following topical otic administration of four different glucocorticoid-containing medications. Veterinary therapeutics: research in applied veterinary medicine. 9(2):111–21.
Rejas López J. 2008. Dermatitis por Malassezia. Revista Electrónica de Veterinaria REDVET: vol. IX, Nº 5. [En línea]. Disponible en: https://www.redalyc.org/pdf/636/63611397010.pdf [Consultado 13/3/2023]
Reuter K, Steinbach A, Helms V. 2016. Interfering with bacterial quorum sensing. Perspectives in Medicinal Chemistry. 8:1-15. https://doi.org/10.4137/PMC.S13209
Rodriguez-Vivas RI, Bolio-González ME, Rosado-Aguilar JA, Gitiérrez-Ruíz E, Torres-Acosta JF, Ortega-Pacheco A, Gutiérrez-Blanco E, Aguilar-Caballero AJ. 2020. Uso de isoxazolinas: alternativa para el control de pulgas, ácaros y garrapatas. Revista Bioagrociencias. [En línea]. Disponible en: https://www.revista.ccba.uady.mx/ojs/index.php/BAC/article/viewFile/3086/1355 [Consultado: 17/3/2023]
Romero M, Acuña L, Otero A. 2012. Patents on quorum quenching: interfering with bacterial communication as a strategy to fight infections. Recent Patents on Biotechnology. 6(1):2-12. https://doi.org/10.2174/187220812799789208
Ruiz SE, Irrazabal MG, Belluzzo Bocco MP, Aguiló Y, Gaut M del C, Pusiol AL, Pereiro L, Giraudo FJ, Rollán M del R. 2020. Hacia una salud: estudio descriptivo de los principales agentes bacterianos de otitis externa y su susceptibilidad a los antimicrobianos, en caninos de la ciudad de Córdoba, Argentina. Revista In Vet. [En línea]. Disponible en: http://www.fvet.uba.ar/archivos/publicaciones/invet/vol22-2-2020/art-2-vol22-2-2020.pdf [Consultado 24/3/2023]
Sainz-Mejías M, Jurado-Martín I, McClean S. 2020. Understanding Pseudomonas aeruginosa-host interactions: the ongoing quest for an efficacious vaccine. Cells. 9(12):2617. https://doi.org/10.3390/cells9122617
Sánchez Ch. R, Calle E. S, Falcón P. N, Pinto J. C. 2011. Aislamiento bacteriano en casos de otitis canina y su susceptibilidad antibiótica. Revista de Investigaciones Veterinarias del Perú. [En línea]. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1609-91172011000200013&lng=es
Santoro D, Marsella R, Pucheu-Haston CM, Eisenschenk M, Nuttall T, Bizikova P. 2015. Review: Pathogenesis of canine atopic dermatitis: skin barrier and host-micro-organism interaction. Veterinary Dermatology. 26(2):84-e25. https://doi.org/10.1111/vde.12197
Saridomichelakis MN, Farmaki R, Leontides LS, Koutinas AF. 2007. Aetiology of canine otitis externa: a retrospective study to 100 cases. Veterinary Dermatology. 18(5):341-7. https://doi.org/10.1111/j.1365-3164.2007.00619.x
Sauvé F. 2019. Use of topical glucocorticoids in veterinary dermatology. The Canadian Veterinary Journal - La Revue Veterinaire Canadienne. 60(7), 785–8.
Sim JXF, Khazandi M, Chan WY, Trott DJ, Deo P. 2019. Antimicrobial activity of thyme oil, oregano oil, thymol and carvacrol against sensitive and resistant microbial isolates from dogs with otitis external. Veterinary Dermatology. 30(6):524-e159. https://doi.org/10.1111/vde.12794
Smeak DD, Inpanbutr N. 2005. Lateral approach to subtotal bulla osteotomy in dogs: pertinent anatomy and procedural details. Compendium on Continuing Education for the Practicing Veterinarian. 27(5):377-85.
Song SY, Hyun JE, Kang JH, Hwang CY. 2020. In vitro antibacterial activity of the manuka essential oil from Leptospermum scoparium combined with Tris-EDTA against Gram-negative bacterial isolates from dogs with otitis externa. Veterinary Dermatology. 31(2):81-5. https://doi.org/10.1111/vde.12807
Souza CP, Ramadinha RR, Scott FB, Pereira MJS. 2008. Factors associated with the prevalence of Otodectes cynotis in an ambulatory population of dogs. Pesquisa Veterinaria Brasileira. 28(8):375-8. https://doi.org/10.1590/S0100-736X2008000800005
Stojkovska J, Djurdjevic Z, Jancic I, Bufan B, Milenkovic M, Jankovic R, Miskovic-Stankovic V, Obradovic B. 2018. Comparative in vivo evaluation of novel formulations based on alginate and silver nanoparticles for wound treatments. Journal of Biomaterials Applications. 32(9):1197-211. https://doi.org/10.1177/0885328218759564
Sultana ST, Atci E, Babauta JT, Falghoush AM, Snekvik KR, Call DR, Beyenal H. 2015. Electrochemical scaffold generates localized, low concentration of hydrogen peroxide that inhibits bacterial pathogens and biofilms. Scientific Reports. 5:14908. https://doi.org/10.1038/srep14908
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N, WHO Pathogens Priority List Working Group. 2018. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. The Lancet. Infectious Diseases. 18(3): 318-27. https://doi.org/10.1016/S1473-3099(17)30753-3
Taenzler J, de Vos C, Roepke RKA, Frénais R, Heckroth AR. 2017. Efficacy of fluralaner against Otodectes cynotis infestations in dogs and cats. Parasites & Vectors. 10(1), 30. https://doi.org/10.1186/s13071-016-1954-y
Tompson AC, Mateus ALP, Brodbelt DC, Chandler CIR. 2021. Understanding Antibiotic Use in Companion Animals: A Literature Review Identifying Avenues for Future Efforts Frontiers in veterinary science. 8:719547. https://doi.org/10.3389/fvets.2021.719547
Toutain PL, Bousquet-Mélou A. 2004. Plasma terminal half-life. Journal of veterinary pharmacology and therapeutics. 27(6):427-39. https://doi.org/10.1111/j.1365-2885.2004.00600.x
Toutain P, Lees P. 2004. Integration and modeling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine Journal of veterinary pharmacology and therapeutics. 27(6), 467–477. https://doi.org/10.1111/j.1365-2885.2004.00613.x
Toutain PL, del Castillo JR, Bousquet-Mélou A. 2002. The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Research in Veterinary Science. 73(2):105-14. https://doi.org/10.1016/s0034-5288(02)00039-5
Vercelli C, Pasquetti M, Giovannetti G, Visioni S, Re G, Giorgi M, Gambino G, Peano A. 2021. In vitro and in vivo evaluation of a new phytotherapic blend to treat acute externa otitis in dogs. Journal of Veterinary Pharmacology and Therapeutics. 44(6):910-8. https://doi.org/10.1111/jvp.13000
Verde M, Navarro L, Villanueva-Saz S, Borobia M, Fernández A. 2021. Tratamiento de las otitis externas. Clindervet. Revista Clínica de Dermatología Veterinaria. Ediciones Veterinarias España, Multimédica. 23:22-34.
Von Silva-Tarouca MSE, Wolf G, Muller RS. 2019. Determination of minimum inhibitory concentration for silver sulfadiazine and other topical antimicrobial agents against strains of Pseudomonas aeruginosa isolated from canine otitis externa. Veterinary Dermatology. 30(2):145-e42. https://doi.org/10.1111/vde.12718
Wang L, Hu C, Shao L. 2017. The antimicrobial activity of nanoparticles: present situation and prospects for the future. International Journal of Nanomedicine. 12:1227-49. https://doi.org/10.2147/IJN.S121956
Wildermuth BE, Griffin CE, Rosenkrantz WS, Boord MJ. 2007. Susceptibility of Pseudomonas isolates from the ears and skin of dogs to enrofloxacin, marbofloxacin, and ciprofloxacin. Journal of the American Animal Hospital Association. 43(6):337-41. https://doi.org/10.5326/0430337
Yoshida N, Naito F, Fukata T. 2002. Studies of certain factors affecting the microenvironment and microflora of the external ear of the dog in health and disease. The Journal of Veterinary Medical Science. 64(12):1145-7. https://doi.org/10.1292/jvms.64.1145
Yotti C. 2021. Otitis externa canina y felina. Clindervet. Revista Clínica de Dermatología Veterinaria. Ediciones Veterinarias España, Multimédica. 23: 2-15
Zhao T, Liu Y. 2010. N-acetylcysteine inhibits biofilm sproduced by Pseudomonas aeruginosa. BMC Microbiology. 10:140. https://doi.org/10.1186/1471-2180-10-140
Zur G, Lifshitz B, Bdolah-Abram T. 2011. The association between the signalment, common causes of canine otitis externa and pathogens. Journal of Small Animal Practice. 52(5):254-8. https://doi.org/10.1111/j.1748-5827.2011.01058.x
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Guillermo Broglia, Andrea Verónica Buchamer, Daniel Buldain, Nora Mestorino, Laura Marchetti
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Los autores/as conservan los derechos de autor y ceden a la revista el derecho de la primera publicación, con el trabajo registrado con la licencia de atribución de Creative Commons, que permite a terceros utilizar lo publicado siempre que mencionen la autoría del trabajo y a la primera publicación en esta revista.
Analecta Veterinaria por Facultad de Ciencias Veterinarias se distribuye bajo una Licencia Creative Commons Atribución-NoComercial-SinDerivar 4.0 Internacional.
